Forward Citations = 1

Loading Chart...

6 inventors (with patents filed for the assignee):

Michael Kaleko (3 out of 63 patents)

Sheila Connelly (3 out of 32 patents)

Pertti Koski (1 out of 11 patents)

4. Ulla Airaksinen (1 out of 12 patents)

5. Katja Valimaki (1 out of 9 patents)

6. Vincent Wacher (1 out of 8 patents)

4 patents: Sort by Forward Citations

1. 11596674 - Method and compositions for inhibiting or preventing adverse effects of oral antibiotics (2023-03-07),

2. 11236319 - Beta-lactamases with improved properties for therapy (2022-02-01),

3. 11214787 - Modified beta-lactamases and methods and uses related thereto (2022-01-04),

4. 11123413 - Carbapenemases for use with antibiotics for the protection of the intestinal microbiome (2021-09-21),

Company Overview

Synthetic Biologies, Inc. is a leading biotechnology company specializing in the research and development of synthetic biology solutions for a wide range of applications. Our innovative technologies allow us to engineer biology to produce sustainable products, improve healthcare outcomes, and address environmental challenges. With a team of experienced scientists and engineers, we are dedicated to advancing the field of synthetic biology to create a better world.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

4 Patents

#126 in Rockville, MD

#895 in Maryland

#60,641 in US

Rockville, MD, United States of America

Synthetic Biologies, Inc.

Forward Citations = 1

6 inventors:

Michael Kaleko (3 out of 63 patents)

Sheila Connelly (3 out of 32 patents)

Pertti Koski (1 out of 11 patents)

4. Ulla Airaksinen (1 out of 12 patents)

5. Katja Valimaki (1 out of 9 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Synthetic Biologies, Inc.. Retrieved from https://idiyas.com/company/synthetic-biologies

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]